Paclitaxel 33069-62-4 Diterpenoid Alkaloid for Antitumor Pharmaceutical Research

Paclitaxel, CAS 33069-62-4, is a natural diterpenoid alkaloid and classic active pharmaceutical ingredient. Isolated from Taxus plant tissues, it features stable chemical structure and potent biological activity. The compound acts as a core antitumor substance, widely recognized for reliable pharmacological performance in pharmaceutical development and clinical medical research.

Paclitaxel is a lipophilic diterpenoid alkaloid with stable physical and chemical properties under sealed and low-temperature conditions. It presents uniform white crystalline powder with low moisture content and few impurities. The compound owns unique and stable molecular conformation, resisting conventional decomposition and structural variation. It shows excellent lipophilic solubility and specific biological targeting activity, maintaining stable pharmacological efficacy in experimental and clinical application environments.

As a mature antitumor API, Paclitaxel is widely used in clinical treatment of breast cancer, ovarian cancer and other malignant tumors. It serves as a key research material for tumor pharmacology and cell biology experiments. It is also an essential raw material for the development of new antitumor drugs and biomedical formulations, meeting high-standard pharmaceutical and scientific research demands.

Store hermetically in low-temperature, dry and dark environment. Avoid high temperature, humidity and strong light exposure. Standard storage effectively maintains structural stability and complete biological activity of the product.